113 related articles for article (PubMed ID: 31311339)
1. The miR-122 inhibition alleviates lipid accumulation and inflammation in NAFLD cell model.
Hu Y; Du G; Li G; Peng X; Zhang Z; Zhai Y
Arch Physiol Biochem; 2021 Oct; 127(5):385-389. PubMed ID: 31311339
[TBL] [Abstract][Full Text] [Related]
2. MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway.
Chen Z; Liu Y; Yang L; Liu P; Zhang Y; Wang X
Immunol Lett; 2020 Jun; 222():40-48. PubMed ID: 32194141
[TBL] [Abstract][Full Text] [Related]
3. Fuzi-Lizhong Decoction Alleviates Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling.
Yang J; Zhang Y; Yi H; Liao Y; Shu L; Zhang S; Li C; An L; Du N; Shi Z; Ma W
Evid Based Complement Alternat Med; 2022; 2022():1637701. PubMed ID: 36065267
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1.
Hu Y; Ye H; Shi LX
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10072-10082. PubMed ID: 31799678
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease.
Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B
Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790
[TBL] [Abstract][Full Text] [Related]
6. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease.
Mahmoudi A; Jalili A; Aghaee-Bakhtiari SH; Oskuee RK; Butler AE; Rizzo M; Sahebkar A
J Diabetes Complications; 2024 Apr; 38(4):108722. PubMed ID: 38503000
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
9. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.
Shen S; Wang K; Zhi Y; Shen W; Huang L
Cell Cycle; 2020 Nov; 19(22):3042-3053. PubMed ID: 33121337
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
Yang JY; Shi ZH; Ma W; Tao DQ; Liu S; Chen L; Zhou XL
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription.
Huang F; Liu H; Lei Z; Li Z; Zhang T; Yang M; Zhou K; Sun C
J Cell Physiol; 2020 Dec; 235(12):9819-9833. PubMed ID: 32413192
[TBL] [Abstract][Full Text] [Related]
12. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.
Chen X; Tan XR; Li SJ; Zhang XX
Life Sci; 2019 Oct; 235():116829. PubMed ID: 31484042
[TBL] [Abstract][Full Text] [Related]
14. TLR2 inhibition ameliorates the amplification effect of LPS on lipid accumulation and lipotoxicity in hepatic cells.
Zhang L; Xie Z; Yu H; Du H; Wang X; Cai J; Qiu Y; Chen R; Jiang X; Liu Z; Li Y; Chen T
Ann Transl Med; 2021 Sep; 9(18):1429. PubMed ID: 34733981
[TBL] [Abstract][Full Text] [Related]
15. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y
Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868
[TBL] [Abstract][Full Text] [Related]
16. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1.
Ao R; Wang Y; Tong J; Wang BF
Med Sci Monit; 2016 Oct; 22():3804-3819. PubMed ID: 27756894
[TBL] [Abstract][Full Text] [Related]
17. lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3.
Jin SS; Lin XF; Zheng JZ; Wang Q; Guan HQ
Eur Cytokine Netw; 2019 Sep; 30(3):98-106. PubMed ID: 31957704
[TBL] [Abstract][Full Text] [Related]
18. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
Chen M; Xing J; Pan D; Peng X; Gao P
Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.
Hu MJ; Long M; Dai RJ
Mol Cell Biochem; 2022 Jan; 477(1):191-203. PubMed ID: 34652536
[TBL] [Abstract][Full Text] [Related]
20. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease.
Zhang H; Yang L; Wang Y; Huang W; Li Y; Chen S; Song G; Ren L
Life Sci; 2020 Sep; 257():118090. PubMed ID: 32679144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
